Skip to content

Prognosis of patients with epilepsy treated by multimodal technique and individualized surgery.

Prognosis of patients with epilepsy treated by multimodal technique and individualized surgery.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043274
Enrollment
Unknown
Registered
2021-02-09
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

multimodal technique and individualized group:Nil
Traditional treatment mode group:Nil

Sponsors

Tangdu Hospital of Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. All enrolled patients received craniotomy for the first time; 2. Lesion site: adjacent to the functional areas of the brain (central sensory, motor and language areas); 3. Patients were treated with personalized surgery, and part of hair was shaved at the incision; 4. At least two trials of antiepileptic drugs have been accepted and failed, meeting the drug resistance criteria; 5. Signed the informed consent for multimodal and personalized surgery projects.

Exclusion criteria

Exclusion criteria: 1. Patients with poor general condition and intolerance to general anesthesia; 2. People with mental illness or serious mental illness; 3. Severe respiratory diseases; 4. Pregnant and lactating women; 5. Participating in another clinical study; 6. Patients with advanced cancer or expected to die within 1 year.

Design outcomes

Primary

MeasureTime frame
Postoperative symptom improvement;

Countries

China

Contacts

Public ContactLiu Bei

Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University

lbsjwk@163.com+86 18192823069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026